Treatment Patterns and Costs Of Neoadjuvant Systemic Therapies (NAT) For Early Breast Cancer (EBC): A Retrospective Claims Analysis
Value Health
.
2014 Nov;17(7):A655-6.
doi: 10.1016/j.jval.2014.08.2393.
Epub 2014 Oct 26.
Authors
Y J Chen
1
,
E Santos
2
,
V Schabert
1
,
V P Antao
2
,
A P De
1
,
C C Portera
2
,
Y Wang
1
,
T Kamath
2
Affiliations
1
IMS Health, Alexandria, VA, USA.
2
Genentech, Inc., South San Francisco, CA, USA.
PMID:
27202374
DOI:
10.1016/j.jval.2014.08.2393
No abstract available